Endoxifen in Treatment of Individuals with Borderline Personality Disorder with Predominant Impulsivity: A Case Series
Endoxifen, a protein kinase C inhibitor, has been approved for use in manic episodes in India. One of the symptom traits that it predominantly targets is impulsivity. Impulsivity can also be a symptom dimension of other mental health conditions, one of which is Borderline Personality Disorder (BPD)....
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Eco-Vector
2023-12-01
|
| Series: | Consortium Psychiatricum |
| Subjects: | |
| Online Access: | https://consortium-psy.com/jour/article/viewFile/13622/pdf |